These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9627564)
1. Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study. Puttagunta AL; Toth EL CMAJ; 1998 Feb; 158(4):506-11. PubMed ID: 9627564 [TBL] [Abstract][Full Text] [Related]
2. Insulin lispro: its role in the treatment of diabetes mellitus. Campbell RK; Campbell LK; White JR Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409 [TBL] [Abstract][Full Text] [Related]
3. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann ME; Haslbeck M; Schatz H; Beyer J Exp Clin Endocrinol Diabetes; 1996; 104(1):25-30. PubMed ID: 8750567 [TBL] [Abstract][Full Text] [Related]
4. Guidelines for using insulin lispro. Toth EL; Lee KC Can Fam Physician; 1998 Nov; 44():2444-9. PubMed ID: 9839062 [TBL] [Abstract][Full Text] [Related]
5. Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group. Renner R; Pfützner A; Trautmann M; Harzer O; Sauter K; Landgraf R Diabetes Care; 1999 May; 22(5):784-8. PubMed ID: 10332682 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Vignati L; Anderson JH; Iversen PW Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449 [TBL] [Abstract][Full Text] [Related]
8. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus. Wilde MI; McTavish D Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963 [TBL] [Abstract][Full Text] [Related]
9. Italian multicentre study of intensive therapy with insulin lispro in 1184 patients with Type 1 diabetes. Valle D; Santoro D; Bates P; Scarpa L; Diabetes Nutr Metab; 2001 Jun; 14(3):126-32. PubMed ID: 11476359 [TBL] [Abstract][Full Text] [Related]
10. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Holleman F; Schmitt H; Rottiers R; Rees A; Symanowski S; Anderson JH Diabetes Care; 1997 Dec; 20(12):1827-32. PubMed ID: 9405901 [TBL] [Abstract][Full Text] [Related]
11. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Garg SK; Carmain JA; Braddy KC; Anderson JH; Vignati L; Jennings MK; Chase HP Diabet Med; 1996 Jan; 13(1):47-52. PubMed ID: 8741812 [TBL] [Abstract][Full Text] [Related]
12. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Ahmed AB; Home PD Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967 [TBL] [Abstract][Full Text] [Related]
13. Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. Ciofetta M; Lalli C; Del Sindaco P; Torlone E; Pampanelli S; Mauro L; Chiara DL; Brunetti P; Bolli GB Diabetes Care; 1999 May; 22(5):795-800. PubMed ID: 10332684 [TBL] [Abstract][Full Text] [Related]
14. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Heller SR; Amiel SA; Mansell P Diabetes Care; 1999 Oct; 22(10):1607-11. PubMed ID: 10526722 [TBL] [Abstract][Full Text] [Related]
15. Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin. Ebeling P; Jansson PA; Smith U; Lalli C; Bolli GB; Koivisto VA Diabetes Care; 1997 Aug; 20(8):1287-9. PubMed ID: 9250455 [TBL] [Abstract][Full Text] [Related]
16. Impact of insulin lispro on HbA1c values in insulin pump users. Garg SK; Anderson JH; Gerard LA; Mackenzie TA; Gottlieb PA; Jennings MK; Chase HP Diabetes Obes Metab; 2000 Oct; 2(5):307-11. PubMed ID: 11225746 [TBL] [Abstract][Full Text] [Related]
17. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus. Burge MR; Waters DL; Holcombe JH; Schade DS J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507 [TBL] [Abstract][Full Text] [Related]
18. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Anderson JH; Brunelle RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R Arch Intern Med; 1997 Jun; 157(11):1249-55. PubMed ID: 9183237 [TBL] [Abstract][Full Text] [Related]
19. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. Lalli C; Ciofetta M; Del Sindaco P; Torlone E; Pampanelli S; Compagnucci P; Cartechini MG; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1999 Mar; 22(3):468-77. PubMed ID: 10097931 [TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Brunelle BL; Llewelyn J; Anderson JH; Gale EA; Koivisto VA Diabetes Care; 1998 Oct; 21(10):1726-31. PubMed ID: 9773738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]